The clinical phenotype of patients with TRAF3 haploinsufficiency (TRAF3HI) is marked by autoimmunity, immunodeficiency, and a predisposition to B cell malignancies, all of which are reminiscent of the immune cell-specific TRAF3 deficient mouse models. This evidence concerns the gene TRAF3 and immune system disorder.